Zobrazeno 1 - 6
of 6
pro vyhledávání: '"A. Yu. Kishkina"'
Publikováno v:
Сибирский онкологический журнал, Vol 18, Iss 5, Pp 38-44 (2019)
Many epidemiological studies have revealed the association between the risk of developing endometrial cancer (EС) and metabolic syndrome (MS) components. A large percentage of patients, especially elderly patients, may have one or more MS components
Externí odkaz:
https://doaj.org/article/179db63bc7124836a30ff032c81f90db
Publikováno v:
Бюллетень сибирской медицины, Vol 18, Iss 2, Pp 299-303 (2019)
We present a rare case of the combination of cervical cancer and unilateral complete aplasia of the uterine adnexa. Female genital tract anomalies account for about 4% of all congenital malformations.Congenital malformations of the adnexa are very ra
Externí odkaz:
https://doaj.org/article/5255f80157c24e3f8c81d15b3f69d43f
Publikováno v:
Опухоли женской репродуктивной системы, Vol 14, Iss 4, Pp 65-71 (2019)
This article reviews the concept of sentinel lymph node biopsy in patients with endometrial cancer. This technique is becoming increasingly appreciated and was included into the latest standards of surgical treatment for gynecological cancers. Sentin
Externí odkaz:
https://doaj.org/article/1483e306d8c3462e883cd1d4da6cefce
Autor:
M. O. Ochirov, L. A. Kolomiets, V. I. Chernov, I. G. Sinilkin, A. L. Chernyshova, A. B. Villert, S. V. Molchanov, O. N. Churuksaeva, A. Yu. Kishkina
Publikováno v:
Сибирский онкологический журнал, Vol 17, Iss 5, Pp 45-51 (2018)
Visualization of sentinel lymph nodes (SLN) is now widely accepted for lymph node (LN) detection using a radioactive lymphotropic trace. Preoperative lymphoscintigraphy with intraoperative lymphatic mapping under gamma detecting probe guidance proved
Externí odkaz:
https://doaj.org/article/cd844eaaf4c44f558cb9d8b24051c76a
Autor:
A. L. Chernyshova, Maxim O. Ochirov, Anastasia Yu. Kishkina, Sergey V. Molchanov, L. A. Kolomiets
Publikováno v:
Онкогинекология. :66-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::982d23cc814e0f411ec18c012c6126a0
https://doi.org/10.52313/22278710_2019_2_66
https://doi.org/10.52313/22278710_2019_2_66
Autor:
Natalia V. Yunusova, Anastasia Yu. Kishkina, Larisa A. Kolomiets, Liudmila V. Spirina, I. V. Kondakova, Sergey G. Afanas’ev
Publikováno v:
Diabetesmetabolic syndrome. 12(5)
Metabolic syndrome (MS) is one of the leading risk factors for the development of some common cancers (endometrial cancer, postmenopausal breast cancer, colorectal cancer). Currently, a drug-induced metabolic syndrome related with androgen deprivatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f443b9d5c511207c3900890c7e1d7643
https://pubmed.ncbi.nlm.nih.gov/29699953
https://pubmed.ncbi.nlm.nih.gov/29699953